| Symbol | FNCHQ |
|---|---|
| Name | FINCH THERAPEUTICS GROUP, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 02109 United States MA 75 State Street Suite100 |
| Telephone | +1 2032731698 |
| Fax | — |
| — | |
| Website | https://www.finchtherapeutics.com/ |
| Incorporation | US |
| Incorporated On | 2017 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Danforth Advisors LLC; |
| Audit Status | AUDITED |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001733257 |
| Description | Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. Finchs objectives are to realize the value of its intellectual property estate through licensing its technology to collaboration partners and enforcing its patent rights against infringing parties through intellectual property litigation and, in certain cases, to generate additional data on selected product candidates through academic collaborations. Additional info from OTC: |
No news found.